Warrants

Amazon has secured warrants to acquire up to $340 million in stock from Generac, a backup power solutions provider. This strategic move, including a $2.4 billion generator supply deal for Amazon’s data centers, sent Generac shares up over 40%. The agreement grants Amazon the right to purchase Generac shares, demonstrating Amazon’s commitment to bolstering its infrastructure, similar to recent investments in Qualcomm and OpenAI.

Daré Bioscience announced a $6 million registered direct offering and private placement of warrants. The offering includes 4,379,581 shares at $1.37 each. Warrants, exercisable after stockholder approval, could add up to 8,759,162 shares, posing potential dilution. The transaction is expected to close around August 17, 2026.

DynaResource announced a non-brokered private placement aiming to raise $3.0 million, with potential to reach $6.4 million through warrant exercise. Units are priced at $0.45, reflecting the 20-day VWAP. Proceeds will fund corporate purposes, working capital, debt service, and capital expenditures for the San José de Gracia project. An advance commitment of $851,250 from existing stockholders has been secured. Completion is contingent on definitive legal documentation.

Colombier Acquisition Corp. III has priced its IPO at $10 per unit, raising $260 million. The special purpose acquisition company’s units will trade on the NYSE under “CLBR U.” Each unit includes a Class A ordinary share and a fraction of a redeemable warrant. The company, a blank check entity, will target businesses where its management team’s expertise offers a competitive edge.

Nuwellis has secured approximately $5 million in gross proceeds through a private placement and warrant inducement. The company sold common stock or pre-funded warrants alongside private placement warrants. Additionally, existing warrants were exercised, and new warrants were issued at a lower strike price. This financing is intended to bolster Nuwellis’s balance sheet, supporting research, development, and operational expenditures in the cardiorenal care sector.

Revelation Biosciences is raising approximately $11 million by exercising outstanding warrants at $0.86 per share. This move also involves issuing new warrants for an additional 26,130,000 shares, contingent on stockholder approval. The capital will support the company’s clinical-stage life sciences operations. This financing strategy, while common, may lead to shareholder dilution. The market’s reaction historically has been mixed to such equity-linked financing.

Ondas Holdings Inc. successfully raised approximately $959.2 million in net proceeds through a registered direct offering. The offering, which included common stock equivalents and warrants, was priced at a premium, signaling strong investor confidence. The capital will fuel corporate development, including strategic acquisitions and investments to drive growth in autonomous systems and private wireless solutions. This substantial funding positions Ondas for expansion and innovation, with potential for an additional $3.4 billion in gross proceeds if warrants are exercised.

Organto Foods is launching an early exercise incentive program to encourage holders of its outstanding warrants to exercise them ahead of schedule. This initiative, pending TSX Venture Exchange approval, offers warrant holders one additional warrant for every three exercised, in exchange for early conversion. If successful, the program could generate significant capital for Organto Foods, potentially up to $6 million, to fund operations and growth. While this strategy can bolster immediate cash flow, it also introduces potential share dilution.

AmeriTrust Financial Technologies has raised $36.19 million in gross proceeds through its initial brokered offering. The funds will be used to restart lease origination activities in Q1 2026 and strengthen working capital. The financing involved the sale of Debenture Units and Life Units, with specific terms for debentures, warrants, and acceleration clauses. This capital infusion supports AmeriTrust’s automotive finance platform and plans for structured risk management in lending. The offering was co-led by Clarus Securities and Cormark Securities, who received commissions and broker warrants. Insider participation is noted as a related-party transaction. A second tranche is expected in January 2026, and the company has an option for further proceeds.

.Miluna Acquisition Corp (NASDAQ: MMTXU) announced that, on or about December 15 2025, unit holders may elect to split their units into ordinary shares and warrants for separate trading. Post‑split, shares will trade under ticker MMTX and warrants under MMTXW, while unsplit units will continue under MMTXU. The split aims to give investors flexibility, potentially enhancing liquidity and price discovery for each security.